Viewing Study NCT04561518


Ignite Creation Date: 2025-12-25 @ 4:40 AM
Ignite Modification Date: 2025-12-26 @ 3:42 AM
Study NCT ID: NCT04561518
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2020-09-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Sponsor: Alnylam Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module